DAFTAR PUSTAKA

Kumar V, Cotran RS, Robbins SL. Buku ajar patologi. 7nd ed , Vol. 1. Jakarta:Penerbit Buku Kedokteran EGC, 2007

AIDS dan Lentivirus. Dalam: Brooks, Butel, Morse. Jawetz, Melnick, & Adelberg’s Medical Microbiology, 23rd Ed. Jakarta: EGC; 2008. 617-32.

Retrovirus and AIDS. Dalam: Richard A Harvey. Microbiology 2nd Edition [e-book]. Baltimore: Lippincott Williams & Wilkins. 2007; 295-303.

Djoerban, Zubairi. HIV/AIDS di Indonesia. Dalam: Aru W. Sudoyo. Buku Ajar Ilmu Penyakit Dalam, Jilid III, Edisi IV. Jakarta: FKUI, 2007.

Human Immunodeficiency Virus Disease: AIDS and Related Disorder. Dalam: A.S. Faucy. Harisson’s Principles of Internal Medicine, 17th ed [e-book]. New York: McGraw-Hill, 2008. Chap.182

WHO. Global Summary of the AIDS Epidemic 2012. Dalam: Core Epidemiological Slides HIV/AIDS Estimates WHO. 2013 [ diakses Juli 2014].http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/201309_epi_core_en.pdf

Dinas Kesehatan Provinsi Kepulauan Riau.Profil kesehatan Provinsi kepulauan riau tahun 2012

P2PL Dinas Kesehatan Kota Batam .2010.KEJADIAN KASUS HIV &AIDS DAN KEMATIAN HIV & AIDS DI KOTA BATAM TAHUN 2006-2009

Palella F, Baker R, Moorman A, Chmiel J, Brooks J, et al (2006). Mortality in the highly active antiretroviral therapy era: changing causes of death and desease in the HIV outpatient study. J Acquired Immune Deficiency Syndrome., 43: 27-34 http://www.medscape.com/viewarticle/547194

Ditjen PPM & PL Depkes RI. Statistik Kasus HIV/AIDS di Indonesia Dilapor s/d Desember 2013.Jakarta:Departemen Kesehatan RI,2003

Ramadian , O (2010). Pengaruh Efek Samping Antiretroviral Lini Pertama Terhadap Adherens ODHA di Layanan Terpadu Rumah Sakit Cipto Mangunkusumo Jakarta, Podiksus HIV/AIDS.

Murphy, R. (2003). Defining the Toxicity Profile of Nevirapine and Other Antiretroviral Drugs. Journal of Acquired Immune Deficiency Syndrome; 34;S15-20.

http://journals.lww.com/jaids/Abstract/2003/09001/Defining_the_Toxicity_Profile_of_Nevirapine_and.4.aspx

Departemen Kesehatan Republik Indonesia.(2006). Pedoman Pelayanan Kefarmasian Untuk Orang Dengan HIV/AIDS (ODHA). Direktorat Bina Farmasi Komunitas dan Klinik Depkes RI.

Departemen Kesehatan Republik Indonesia . (2011). Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral Pada Orang Dewasa. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan Depkes RI.

Katzung, B. (2004). Basic and Clinical Pharmacology, 8th Edition; 1130-1155, USA; Mc.Graw Hill Companies.Inc

Numez MJ. Martin-Carbonero L, Moreno V, Valencia E, Gracia-Samaniego J, et al. Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients. AIDS Res Hum Retroviruses 2006; 22:825-829.

Hernandez L, Gilson I, Jacobson J, Affi A, Puetz T, Dindzans V. Antiretroviral hepatotoxicity in HIV-infected patients. Aliment Pharmacol Ther 2001; 15:1627-1632.

Pollard RB, Robinson P, Dransfield K. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther. 1998 Nov-Dec; 20(6): 1071-92.

Wit FW, Weverling GJ, Weel J, Jurriaans S, Lange JM. Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy. J Infect Dis. 2002 Jul 1; 186(1): 23-31

Leith J, Piliero P, Storfer S, Mayers D, Hinzmann R. Appropriate use of nevirapine for long-term therapy. J Infect Dis. 2005 Aug 1;192(3): 545-6

Sanne I, Mommeja-Marin H, Hinle J, Bartlett J, Lederman M, Maartens G, et al. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects. J Infect Dis 2005; 191;825-829.

De Maat M, Mathot R, Veldkamp A, Huitma A, Mulder J, Meenhorst P, et al. Hepatotoxicity following nevirapine containing regimens in HIV-1-infected individuals. Pharmacol Res 2002; 46:295-300

Johnshon S, Chan J, Bennett C. Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Ann Intern Med 2002; 137:146-147